Based on our Pharmacor advisory service entitled Obesity Decision Resources is offering an exclusive Pharmacor analyst call entitled How Will Sibutramine’s Suspension in Europe Affect its Future in the United States and What Now Lies Ahead for the Obesity Drug Market? Because this analyst call features major updates, it is ONLY available to purchasers of this Pharmacor advisory service.

 

This analyst call was held on February 11, 2010. Contact us to learn how you can purchase this Pharmacor advisory service and access a recorded playback of this event.

Click here to view the invite.